The Journal of the Pharmacy Society of Wisconsin
  • Home
  • Past Issues
    • Journal Archives
    • JPSW 2026
    • JPSW 2025
    • JPSW 2024
    • JPSW 2023
    • JPSW 2022
    • JPSW 2021
    • JPSW 2020
    • JPSW 2019
    • JPSW 2018
    • JPSW 2017
  • JPSW Supplements
  • Open-Access Series
    • Preceptor Development Series
    • Statistics Review Series
  • For Authors and Reviewers
    • Author Guidelines
    • CE Author Guidelines
    • Case Report Author Guidelines
    • Types of Manuscripts
    • Peer Review Information
    • Emerging Writers Course
    • Submit a Manuscript
  • Contact
    • Editorial Advisory Committee

CE for Pharmacists & Technicians: Penicillin G to be Syphilis Free: A Review of Common Sexually Transmitted Infections

by Chloe Kotrba, PharmD, Philip (Logan) Whitfield, PharmD, BCIDP, Allison Gibble, PharmD, BCIDP

Learning Objectives:
  • Describe the scope of the sexually transmitted infections (STI) epidemic (P,T)
  • Summarize differences in diagnostic testing for chlamydia, gonorrhea, and syphilis (P,T)
  • Identify important changes in STI treatment recommendations (P)
  • Identify the different stages of syphilis and appropriate treatment recommendations for each stage (P,T)
  • Explain the pharmacy's role in the furnishment of expedited partner therapy for chlamydia, gonorrhea, and trichomoniasis (P,T)
  • Select appropriate STI treatment options for special populations such as pregnant women, patients with high body weight, and patients with antibiotic allergies (P)

Abstract:
Sexually transmitted infections (STIs) include any bacterial, viral, or parasitic infections spread through sexual contact. These infections place a significant burden on healthcare systems due to the potential for disease progression, ease of transmission, and possibly complex treatment regimens. Despite improvements in testing, screening, and public education, common STIs such as chlamydia, gonorrhea, and syphilis continue to have substantial case numbers in the United States. This article aims to provide a detailed overview of each of these common STIs and their guideline-recommended treatment regimens, as well as the utility of expedited partner therapy (EPT) and post-exposure prophylaxis (PEP).
​
​

Download PDF

2026 March/April Table of Contents

The Journal of the Pharmacy Society of Wisconsin (ISSN 2837-8229)


Past Issues

2026

2025
2024
2
023
2020
2021
​2022
2019
2018
2017

About PSW

www.pswi.org

Contact Us

[email protected]
  • Home
  • Past Issues
    • Journal Archives
    • JPSW 2026
    • JPSW 2025
    • JPSW 2024
    • JPSW 2023
    • JPSW 2022
    • JPSW 2021
    • JPSW 2020
    • JPSW 2019
    • JPSW 2018
    • JPSW 2017
  • JPSW Supplements
  • Open-Access Series
    • Preceptor Development Series
    • Statistics Review Series
  • For Authors and Reviewers
    • Author Guidelines
    • CE Author Guidelines
    • Case Report Author Guidelines
    • Types of Manuscripts
    • Peer Review Information
    • Emerging Writers Course
    • Submit a Manuscript
  • Contact
    • Editorial Advisory Committee